首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到19条相似文献,搜索用时 62 毫秒
1.
目的:评估Caprini静脉血栓风险评估量表(简称Caprini量表)在妇科恶性肿瘤手术患者中对静脉血栓栓塞症(VTE)的预测效果,分析妇科恶性肿瘤手术患者术后VTE的危险因素,并构建VTE风险预测模型.方法:采用回顾性队列研究分析中山大学肿瘤防治中心2015年1月至2020年12月诊治的妇科肿瘤患者手术后确诊VTE的...  相似文献   

2.
目的:探讨妇科手术患者静脉血栓栓塞症(VTE)的危险因素和改良VTE评估模型对妇科手术患者VTE发生风险的预测价值。方法:选择2020年1月1日至2022年12月31日妇科手术后并发VTE患者41例为血栓组,按照1∶4的比例抽取同期妇科手术患者164例作为非血栓组。运用单因素及多因素Logistic回归分析妇科手术后并发VTE的危险因素,构建改良VTE危险因素快速评估模型(简称改良VTE评估表),应用受试者工作特征(ROC)曲线分析其对妇科手术患者VTE的预测价值,并与Caprini血栓风险评估模型(简称Caprini量表)进行比较。结果:(1)多因素Logistic回归分析结果示,年龄≥60岁、体质量指数(BMI)≥28 kg/m2、恶性肿瘤、手术时间>3小时、血栓病史、手术前后D-二聚体(D-D)差值增大是影响妇科手术后并发VTE的独立危险因素(OR>1,P<0.05)。(2)改良VTE评估表的ROC曲线下面积(AUC)为0.963,约登指数81.10%、敏感度87.80%、特异度93.29%;Caprini量表的AUC为0.888,约登指数63.41%、敏感度73.17%、特异度90.24%。改良VTE评估表和Caprini量表分别可将92.68%和85.37%的VTE患者评估为高危或极高危,但差异无统计学意义(P<0.05)。结论:对于影响妇科手术患者VTE的6项独立危险因素临床上应重点关注。改良VTE评估表与Caprini量表对VTE识别水平相当,但其简单、易操作,具有更好的实用性,有一定的临床推广价值。  相似文献   

3.
目的:探讨妇科手术患者静脉血栓栓塞症(VTE)危险因素及制定VTE危险因素评分简表,并对评分简表进行有效性验证。方法:收集2015年10月至2017年10月在西安交通大学第一附属医院妇科接诊并手术治疗后并发VTE的妇科肿瘤患者53例,对照组选择时间上相邻的2个妇科手术非VTE妇科肿瘤患者共106例。对年龄、体质量指数(BMI)、肿瘤性质、血栓相关病史、合并症、手术方式、手术时间、出血量、术后卧床时间、妊娠或产褥期、激素服用史进行单因素分析和多因素分析,并制定VTE危险因素的评分简表,应用该评分简表和Caprini评分表对所有患者进行评分比较。结果:单因素分析中,两组在BMI、肿瘤性质、手术时长、出血量、有无输血、卧床时间、血栓相关病史等方面差异有统计学意义(P0.05)。多因素Logistic回归结果,年龄60岁、BMI28 kg/m~2、恶性肿瘤、手术时长≥3小时、腹腔镜手术、血栓相关病史是影响妇科手术患者并发VTE的独立危险因素(P0.05)。评分简表与Caprini评分表评分情况比较,两者差异无统计学意义(P0.05)。结论:年龄大、BMI高、恶性肿瘤、手术时间长、腹腔镜手术及有血栓相关病史患者妇科手术后更易发生VTE。评分简表简便易操作且对于VTE识别度高,有一定临床实用价值。  相似文献   

4.
目的:探讨妇科手术后静脉血栓性疾病(VTE)的发生率、危险因素及其诊断和治疗.方法:回顾性分析我院2003年1月至2008年11月期间,确诊为妇科手术后VTE 27例患者的临床情况,其中下肢静脉血栓(DVT)26例,肺栓塞(PE)1例.结果:妇科手术后VTE总发生率为0.27%,其中恶性肿瘤1.59%,良性疾病0.02%,恶性肿瘤明显高于良性疾病(P<0.01).卵巢癌的VTE发生率为3.43%,明显高于宫颈癌(0.71%)和子宫内膜癌(0.74%)(P<0.05).行盆腔淋巴结清扫显著增加VTE发生率.DVT患者经彩色多普勒超声检查确诊,PE患者经CT肺血管三维扫描确诊.结论:妇科盆腔手术后VTE发生率低,但有增加趋势.恶性肿瘤,尤其是卵巢癌和行盆腔淋巴结清扫术是VTE发生的危险因素.正确诊断、及时治疗愈后好.  相似文献   

5.
目的:探讨妇科恶性肿瘤患者术后静脉血栓栓塞疾病(VTE)发生的危险因素及其预防措施。方法:回顾分析32例北京大学人民医院诊治的术后VTE的妇科恶性肿瘤患者临床资料,并与具有相同高危因素,包括高血压、糖尿病、高血脂但术后未发生VTE的61例妇科恶性肿瘤患者的临床资料进行对比分析。结果:血栓组与对照组比较,脂肪肝(χ2=5.056,P=0.025)、术后化疗(χ2=13.657,P<0.001)及围手术期给予止血药物(χ2=12.007,P=0.001)明显增加VTE的发生率,而术中化疗(χ2=8.233,P=0.004)及术后采用抗凝等预防措施(χ2=18.582,P<0.001)则显著降低VTE的发生率。而其余因素两组间无统计学差异。Logistic回归分析提示围手术期给予止血药物与术后VTE的关系最密切,OR为6.129(1.242,30.239)。VTE使得患者住院时间明显延长(P=0.010)。结论:妇科恶性肿瘤患者术后发生VTE的可能性大,术前应进行危险因素评估,对于合并高血压、糖尿病、高血脂、脂肪肝、术后化疗以及围手术期接受止血药物治疗的患者,应采取积极的多种联合预防措施,以减少术后VTE的发生。  相似文献   

6.
静脉血栓栓塞症(VTE)包括深静脉血栓形成和肺栓塞,是妇科常见的围手术期并发症,严重威胁患者生命安全。如今,VTE已逐渐引起人们的重视,VTE预防不容忽视。结合中国妇科术后VTE防治经验,2017年制定了“妇科手术后深静脉血栓形成及肺栓塞预防专家共识”。文章就妇科围手术期VTE预防的重要性及预防措施进行详解。  相似文献   

7.
目的 分析妇科恶性肿瘤住院手术治疗患者的围术期静脉血栓栓塞症(VTE)发生的高危因素。方法 纳入本市电子病历系统登记的初次手术治疗的妇科恶性肿瘤患者共2364例,根据围术期是否发生VTE分为[VTE(+)组,110例],其他纳入对照组[VTE(-)组,2254例]。分析发生VTE的高危因素。结果 妇科恶性肿瘤患者围术期VTE发生的高危因素包括年龄≥57.5岁、合并高血压、合并糖尿病、开腹手术、病理类型为子宫内膜癌。结论 妇科恶性肿瘤手术患者围术期VTE的发生受多种因素影响,在诊疗过程中应对患者进行评估并对具有高危因素患者采取预防措施,以减少围术期VTE发生,促进患者康复。  相似文献   

8.
目的:探讨孕产妇静脉血栓栓塞症(VTE)的临床特征、危险因素及其预防措施。方法:选取2013年5月~2019年9月在四川大学华西第二医院住院并诊断为VTE孕产妇的临床资料74例作为病例组,1∶3匹配选择222例非VTE对象作为对照组。收集病例-对照组临床资料,应用成组t检验及Cox回归模型进行分析。结果:产褥期孕产妇VTE发病率高,好发于下肢静脉血栓(71.62%),深静脉血栓主要症状为肢体肿胀(71.62%)、疼痛(43.24%),而肺栓塞者主要表现为低氧血症(14.86%),少见胸闷、咳嗽(2.7%)。Cox回归模型多因素分析结果显示高龄(OR 1.895,P=0.022)、VTE病史(OR 2.145,P=0.044)、静脉曲张(OR 6.559,P=0.010)、制动(OR 2.293,P=0.004)、胎死宫内(OR 3.509,P=0.020)、急诊剖宫产(OR 4.824,P=0.001)、择期剖宫产(OR 2.916,P=0.01)及多胎妊娠(OR 2.225,P=0.009)为我院孕产妇VTE发生的危险因素。结论:早期识别妊娠相关VTE的危险因素,进行有效的院内妊娠相...  相似文献   

9.
静脉血栓栓塞症(VTE)包括深静脉血栓形成(DVT)和肺栓塞(PE),是妇产科常见的严重并发症,其发展迅速,病死率高。VTE重在风险评估和疾病预防,文章就国内外相关文献,结合自身经验总结妇产科临床常见的VTE高危因素及其潜在机制。  相似文献   

10.
静脉血栓栓塞症(venous thromboembolism, VTE)是妇产科围手术期严重的并发症,是导致围手术期患者死亡的重要原因之一。围手术期对患者进行VTE发生危险评估、分级,并根据科学评估后的危险分级采取正确的预防措施,包括物理治疗及药物预防,对于降低VTE的发生风险具有重要的意义。  相似文献   

11.
目的:探讨改良Caprini血栓风险评估量表预测妊娠相关静脉血栓栓塞疾病(pregnancy associated venous thromboembolism,PA-VTE)的价值。方法:采用病例对照研究,以2012年10月—2019年10月在北京大学第三医院产科住院的49例PA-VTE病例为研究组,随机抽取同期非PA-VTE病例98例作为对照组。比较2组在改良Caprini血栓风险评估量表PA-VTE发病危险因素中的差异;利用Caprini血栓风险评估量表及改良Caprini血栓风险评估量表对2组病例进行PA-VTE发病风险评分及危险度分级,分析危险度分级与PA-VTE发病风险的相关性;同时评估改良Caprini血栓风险评估量表对PA-VTE的预测能力。结果:(1)年龄、体质量指数(BMI)≥25 kg/m2、早产、胎儿生长受限、择期剖宫产、卧床、遗传性易栓症、内科合并症、深静脉血栓或肺栓塞病史是PA-VTE发生的主要危险因素(均P<0.05)。(2)Caprini血栓风险评估量表及改良Caprini血栓风险评估量表的危险度分级与PA-VTE发病均存在显著的“剂量反应”关系(...  相似文献   

12.
妊娠相关静脉血栓栓塞症(pregnancy associated venous thromboembolism,PA-VTE)包括妊娠期和产褥期发生的静脉系统的血栓形成疾病,由深静脉血栓形成(deep vein thrombosis,DVT)和肺栓塞(pulmonary embolism,PE)组成的PA-VTE是发达国家孕产妇发病和死亡的主要原因。采用高效、便捷的风险评估模型评估PA-VTE的发病风险并进行分级预防是目前多个国家推荐的主要措施,但由于各国医学水平、经济发展和传统习惯的不同,各国相继开发风险评估模型或根据实际情况对其他国家的风险评估模型进行改良,进而对妊娠期及产褥期VTE风险进行个体化评估,并实施相应的血栓预防策略。通过回顾国内外的PA-VTE风险评估模型,旨在为我国进一步建立孕产妇的VTE防治指南提供依据,为产科医务工作者制定出适合我国产科人群的VTE风险评估模型提供参考。  相似文献   

13.
Venous thromboembolism (VTE) is the leading cause of preventable healthcare-related death after surgery. Although there is a large body of research on VTE in the general population as well as risk-assessment tools, evidence specific to the current practices in gynecologic surgery is more sparse. This review article seeks to discuss current literature on VTE in gynecologic surgery, with a focus on minimally invasive surgery. Evidence on risk factors for VTE in gynecologic surgery is evaluated as well as current recommendations use of thromboprophylaxis for prevention of VTE. Despite data showing that minimally invasive gynecologic surgery independently decreases risk of VTE compared with laparotomy, current clinical risk assessment tools and guidelines do not incorporate mode of surgery into recommendations for perioperative VTE prevention.  相似文献   

14.
BackgroundThe number of adolescents who are prescribed hormonal contraception (HC) for contraceptive and noncontraceptive indications is increasing. Approximately 1 of 4 female adolescents will use some form of HC by age 19 years. Venous thromboembolism (VTE) is a rare, but life-threatening complication associated with HC use. Although adolescents aged 15 to 19 years have the lowest absolute HC-associated VTE risk, they still account for 5.9% of HC-associated VTE. The absolute HC-associated VTE risk for those younger than 15 years of age is not well described.ObjectiveThe objectives of this report are to describe the current literature regarding HC-associated VTE in adolescents, to review the coagulation cascade and in vivo coagulation, to highlight differences between the adolescent and adult coagulation profiles, to discuss coagulation profile changes related to HC use, and to identify knowledge deficits for future study.ConclusionThe mechanisms and confounding variables that lead to HC-associated VTE in all adolescents are not well understood because many large HC studies exclude female adolescents younger than 18 years of age. Because of the paucity of data in this age group, observational studies and randomized controlled trials of VTE risk in adolescents on varying forms of HC are needed. Studies should include female adolescents across the entire adolescent age span (12-21 years) to better understand HC-associated VTE risk in this population.  相似文献   

15.

Study Objective

Our goal was to describe the period prevalence of venous thromboembolism (VTE) and characterize adolescent female patients diagnosed with VTE by describing their age, race, and number of comorbidities. Female adolescents with estrogen exposure were of particular interest because estrogen-containing contraceptives increase the risk of VTE.

Design, Setting, Participants, and Interventions

We queried the Pediatric Health Information System database for International Classification of Diseases, Ninth/Tenth Revision, Clinical Modification codes to identify female patients aged 12-18 years diagnosed with a VTE or pulmonary embolism from April 2006 to March 2016 in the United States. Patient demographic characteristics and comorbidities were also analyzed. We divided our study population into two five-year groups and calculated the change in period prevalence of VTE between those groups.

Main Outcome Measures

Primary diagnosis of VTE in the extremities, or pulmonary embolism.

Results

The period prevalence of VTE increased from 2.3 female adolescents per 10,000 hospitalized children (group 1) to 3.3 per 10,000 (group 2), representing a statistically significant increase of 0.010% (P < .001). Caucasian and black individuals were most commonly affected. The number of girls affected increased steadily from ages 12 to 16 years and a large percentage (59.6%) had four or more comorbidities. In patients (n = 32) with estrogen exposure, more than 96% had one or more comorbidity in addition to estrogen exposure.

Conclusion

Pediatric health care providers should be aware that the period prevalence of VTEs in female adolescents is increasing. Those with a history of estrogen exposure rarely develop VTEs from estrogen alone and they typically have multiple comorbidities.  相似文献   

16.
17.
妇科盆腔手术后下肢深静脉血栓形成的早期诊断   总被引:4,自引:0,他引:4  
目的:探讨妇科盆腔手术后下肢深静脉血栓形成的早期诊断方法。方法:采用D-二聚体(D-dimer)与彩色多普勒超声对141例妇科盆腔手术后患者进行检查,对其中超声诊断的4例下肢静脉血栓患者行下肢静脉造影。结果:彩色多普勒超声检查出小腿静脉血栓22例,4例行下肢静脉造影的结果与超声诊断相符。D-dimer的敏感性为95.5%,特异性为60.5%,准确性为66%,阳性预测值为30.8%,阴性预测值为98.6%。结论:D-dimer联合彩色多普勒超声检查可作为妇科盆腔手术后下肢深静脉血栓形成的早期诊断方法。  相似文献   

18.
Objective: To achieve absolute risk estimates of venous thromboembolism (YTE) among women on cyproterone acetate plus ethinylestradiol (CPA/EE), and among women on combined oral contraceptives (COCs).Methods: From the Danish National Register of Patients (NRP), 1996 to 1998, the records of 1.1 million Danish women, ages 15 to 44 years, were searched for evidence of VTE. COC use was ascertained through mailed questionnaires. Sales statistics of COCs and CPA/EE were provided through Danish Drug Statistics.Results: During the time frame of the study, 330 women were found to have had VTE while on COCs. Of these women, 67 were on levonorgestrel-containing COCs. Eleven were on CPA/EE. The corresponding absolute risk of VTE was 3.4 (range, 3.1-3.8) per 10 000 women years among the women on COCs, 4.2 (range, 3.2-5.2) per 10 000 women years among women on levonorgestrel-containing COCs, and 3.1 (range, 1.3-4.9) per 10 000 women years among the women on CPA/EE.Conclusion: Our Results suggest the absolute risk of VTE among Danish women on COCs is similar to that among women taking CPA/EE.  相似文献   

19.
置入心脏起搏器患者施行妇产科手术的体会   总被引:1,自引:0,他引:1  
目的:探讨缓慢心律失常患者置入心脏起搏器后经历妇产科手术的临床情况。方法:回顾分析37例伴有缓慢心律失常的孕产妇及妇科患者置入人工心脏起搏器后施行剖宫产或妇科手术的围手术期情况及术中高频手术器械对心脏起搏器的影响。结果:总计在已置入31例临时和6例永久性起搏器的患者中,10例孕产妇顺利施行剖宫产,27例妇科患者顺利施行经腹全子宫加附件切除、宫腹腔镜等手术;32例使用高频双极电刀电凝或双极切割套圈对起搏器无干扰,5例单极电刀干扰或抑制起搏器。结论:置入心脏起搏器可使患有严重缓慢心律失常的妇产科患者安全度过围手术期;妇产科手术中应用高频手术器械应尽可能选用对起搏器无影响的双极电刀电凝。  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号